Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 26, 2010JDDG Journal der Deutschen Dermatologischen Gesellschaft

Combination therapy with extracorporeal photopheresis, interferon‐α, PUVA and topical corticosteroids in the management of Sézary syndrome

View Full Paper
Ask AI
Bookmark
Share

Authors

NBNina BookenUniversität HamburgCWChristel WeißHeidelberg UniversityJUJochen UtikalGerman Cancer Research Center

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Booken et al. (2010) studied this question.

synapsesocial.com/papers/6a9cfb54a12dd0bd49a8ab5ehttps://doi.org/10.1111/j.1610-0387.2010.07319.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1U.K. consensus statement on the use of extracorporeal photopheresis for treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease2008 · 174 citations
  2. 2Treatment of advanced mycosis fungoides/Sezary syndrome with fludarabine and potential adjunctive benefit to subsequent extracorporeal photochemotherapy2004 · 42 citations
  3. 3Extracorporeal Photopheresis in Sézary Syndrome1998 · 92 citations
  4. 4Extracorporeal Photopheresis of Cutaneous T-Cell Lymphoma Is Associated with Reduction of Peripheral CD4+ T Lymphocytes1998 · 32 citations